Lindsay Talbot

Thrilled to announce our latest publication in @ScienceMagazine describing a reverse-translation study that defines the core regulators of T cell stemness that can be exploited to improve immunotherapy! @TaeGunKang2 @StJudeResearch @SU2C @VAInstitute science.org/doi/10.1126/sc…

Come to think of it, denigrating the worth of a soldier’s service based on whether he deployed to a war zone is… kind of like denigrating the worth of a woman’s citizenship based on whether she happens to have children.

It’s a great day when years of research comes out to the world! Great work from a great team! @StJudeResearch stjude.org/media-resource…

Scientists identified chemokines expressed by osteosarcoma that enhanced CAR T-cell homing, presenting a promising new strategy to improve antitumor activity. This work is a significant step forward in the development of immunotherapy for solid tumors. ow.ly/Y7pn50SRv35

Don’t forget to check out @LindsayJTalbot poster on her #PSORC study investigating the use of palliative site-directed ablative therapy in pediatric oncology @AmerAcadPeds #AAP2023. Great work!

Check out our recent study in BioRxiv! A high-throughput screen to identify small molecules that enhance antigen expression to enhance B7-H3 #CART cells targeting #osteosarcoma. A collaboration between the @DeRenzoLab & Dr. Taosheng Chen @StJudeResearch biorxiv.org/content/10.110…

Our ACS National Surgeon Scientist Program (NSSP) and NCI Early-stage Surgeon Scientist Program (ESSP) awardees met on NIH's campus today for their first in-person symposium! A huge thank you to our experts for joining. @theNCI @NCI_Training @NIH @AmCollSurgeons

So blessed to be part of the @DukeSurgery family! #pedsurgbestsurg

@LisaTracyMD @RyanAntiel @APSASurgeons @CarrieBMoore1 @DukeSurgRes @dukepedssurgery So great seeing everyone and meeting the new generation!

More fun times with the #DukeCrew at ⁦@APSASurgeons⁩! ⁦@CarrieBMoore1⁩ ⁦@DukeSurgRes⁩ ⁦@dukepedssurgery⁩

Great showing from @dukepedssurgery today at #APSA2023 on topics ranging from global surgery to biliary surgery to cancer control plans! @DukeSurgRes @HaroldLeraas @LisaTracyMD

⁦@LindsayJTalbot⁩ speaking in Young Investigator Symposium ⁦@APSASurgeons⁩ on leveraging CAR T cell strategies to improve osteosarcoma outcomes! Phenomenal work from an outstanding pediatric surgeon scientist! 🙌👏👊 ⁦@StJude⁩

@BoLovvorn @APSASurgeons @StJude Thanks Dr. Lovvorn so excited to be there and especially in Dr. Kandel's presidency...talk about mentors and advocates!

First corresponding paper is out! Thank you to @Jorge88382322 and @GiedreKrenciute for the beautiful imaging and brain tumor models, Lindsay Talbot for the stunning HALO assay, and @Kyttaro_Therapy for the mentorship and support. All made possible by @StJude and @StJudeResearch

Excited to share Peter Chockley's work on Synapse-tuned CARs out in Nature Biotech today @NatureBiotech @Kyttaro_Therapy @StJudeResearch Synapse-tuned CARs enhance immune cell anti-tumor activity | Nature Biotechnology nature.com/articles/s4158…

“We've come up with a way to more efficiently and effectively bind and target cancer cells,” @PeterChockley says. Discover how his ‘molecular anchor’ improved chimeric antigen receptors against multiple cancer types in @NatureBiotech. stjude.org/CAR-anchor-dom… #immunotherapy

Get to know our new Program Director, Dr Bethany Slater! @bslatermd specialty: pediatric surgery hometown: NYC when outside the hospital she might be: running a marathon, traveling the world, playing tennis, or trying out a new restaurant favorite part of the job: helping kids

Inspiring talk today at @StJude from pediatric surgical oncologist Dr. @LindsayJTalbot on building a program to leverage chemokine-mediated homing of CAR T cells in pediatric #osteosarcoma. 🔬@StJudeResearch

Yes we are! My laboratory is looking for a senior or lead research technician to take on challenging projects in immune profiling of osteosarcoma tumors and surgical modeling! Please take a look amd consider joining this highly cohesive and collaborative group!